Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study

MLA

Relinde I Y Lieverse, et al. “Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.” International Journal of Radiation Oncology*Biology*Physics, Jan. 2021. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2020.11.053.

APA

Relinde I Y Lieverse, Jaap D. Zindler, Ruud Houben, Chantal Overhof, Frans Verhelst, Alida A. Postma, Ann Hoeben, Philippe Lambin, Evert J. Van Limbergen, Ludwig Dubois, Dirk De Ruysscher, & Esther G.C. Troost. (2021). Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2020.11.053

Chicago

Relinde I Y Lieverse, Jaap D. Zindler, Ruud Houben, Chantal Overhof, Frans Verhelst, Alida A. Postma, Ann Hoeben, et al. 2021. “Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.” International Journal of Radiation Oncology*Biology*Physics, January. doi:10.1016/j.ijrobp.2020.11.053.